Dummer R, et al. J. Am. Acad. Dermatol (2016) cited as Ref 600 in DOI: 10.1038/s41392-020-0110-5 (Q9863)
Revision as of 22:05, 20 May 2020 by Admin (talk | contribs) (Created claim: Property:P93: The 12-month analysis from basal cell carcinoma outcomes with LDE225 treatment (BOLT): a phase II randomized double-blind study of sonidegib in patients with advanced basal cell carcinoma, #quickstatement...)
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Dummer R, et al. J. Am. Acad. Dermatol (2016) cited as Ref 600 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Dummer R
0 references
2016
0 references
J. Am. Acad. Dermatol
0 references
75
0 references
The 12-month analysis from basal cell carcinoma outcomes with LDE225 treatment (BOLT): a phase II randomized double-blind study of sonidegib in patients with advanced basal cell carcinoma (English)
0 references
